Financhill
Back

Catalyst Pharmaceuticals 10K Form

Buy
72

CPRX
Catalyst Pharmaceuticals

Last Price:
16.63
Seasonality Move:
2.54%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CPRX News And Ratings

See the #1 stock for the next 7 days that we like better than CPRX

CPRX Financial Statistics

Sales & Book Value

Annual Sales: $140.83M
Cash Flow: $41.3M
Price / Cash Flow: 19.35
Annual Sales: $2.59
Price / Book: 6.46

Profitability

EPS (TTM): 0.61000
Net Income (TTM): $66.92M
Gross Margin: $118.95M
Return on Equity: 29.43%
Return on Assets: 25.57%

Catalyst Pharmaceuticals Earnings Forecast

Key Catalyst Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 20 years for CPRX is 84.46%.
  • The Selling, General & Administrative Expenses for CPRX have been equal to 35.24% of Gross Profit Margin.
  • The Research & Development expenses have been 12.03% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 20 years have been positive in 10 years.

Catalyst Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: CPRX
CUSIP: 14888U
Website: catalystpharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 6.18
Quick Ratio: 5.95

Price-to-Earnings

Trailing P/E Ratio: 45.31
Forward P/E Ratio: 18.84

CPRX Technical Analysis vs Fundamental Analysis

Buy
72
Catalyst Pharmaceuticals (CPRX) is a Buy

Is Catalyst Pharmaceuticals a Buy or a Sell?